Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.

Saved in:
Bibliographic Details
Title: Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
Authors: Patel GK; Department of Oncologic Sciences, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Perry JB; College of Allied Health Professions, The University of South Alabama, Mobile, Alabama, USA., Abdul-Rahim O; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA., Frankel AE; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Cameron D; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Taylor W; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Rocconi RP; Gynecology Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Abushahin L; Medical Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Nelson C; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA., Singh AP; Department of Oncologic Sciences, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA., Khushman M; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA.
Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2020 Jul-Sep; Vol. 16 (4), pp. 950-954.
Publication Type: Case Reports; Journal Article; Review
Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1998-4138
DOI:10.4103/jcrt.JCRT_729_18